Empresa Chimeric Therapeutics Limited
Acciones
CHM
AU0000121576
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,024 AUD | +4,35 % | +4,35 % | -31,43 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jennifer Chow
CEO | Chief Executive Officer | - | 01/12/20 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 12/07/23 |
Chief Tech/Sci/R&D Officer | - | 05/07/22 | |
Li Ren
CTO | Chief Tech/Sci/R&D Officer | - | 25/06/21 |
Jason B. Litten
CTO | Chief Tech/Sci/R&D Officer | 50 | 25/07/22 |
Elizabeth Chang
PRN | Corporate Officer/Principal | - | - |
Eliot Bourk
PRN | Corporate Officer/Principal | - | 23/02/21 |
Nathan Jong
SEC | Corporate Secretary | - | - |
Alison Gartner
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 60 | 03/02/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Lesley Russell
BRD | Director/Board Member | 63 | 28/08/20 |
Paul Hopper
FOU | Founder | 68 | 02/02/20 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 12/07/23 |
Eric Sullivan
BRD | Director/Board Member | - | 30/08/23 |
Jennifer Chow
CEO | Chief Executive Officer | - | 01/12/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 725 840 586 | 652 667 576 ( 89,92 %) | 0 | 89,92 % |
Información de la empresa
Chimeric Therapeutics Ltd. (Australia)
62 Lygon Street Level 3
3053, Carlton
+
http://www.chimerictherapeutics.comSector
Revisiones del BPA
Ganancias trimestrales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-31,43 % | 13,14 M | |
+8,63 % | 114 mil M | |
+13,17 % | 107 mil M | |
-12,76 % | 22,22 mil M | |
-2,77 % | 21,28 mil M | |
-7,19 % | 17,51 mil M | |
-39,93 % | 17,17 mil M | |
+6,67 % | 14,14 mil M | |
+33,90 % | 12,2 mil M | |
-28,60 % | 7830,9 M |
- Bolsa de valores
- Acciones
- Acción CHM
- Empresa Chimeric Therapeutics Limited